ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 625

$518K Total Retail Price of All Prescriptions

Rank: 174 out of 625

494 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,747 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 497 452 1 1
LEVOTHYROXINE SODIUM 452 348 2 3
SIMVASTATIN 407 349 3 2
HYDROCODONE-ACETAMINOPHEN 364 237 S3 4 4
LISINOPRIL 352 292 5 5
HYDROCHLOROTHIAZIDE 309 257 6 12
CITALOPRAM HBR 295 242 7 24
ZOLPIDEM TARTRATE 251 200 8 13
OMEPRAZOLE 220 152 9 6
GABAPENTIN 218 179 10 14
METOPROLOL TARTRATE 203 184 11 11
POTASSIUM CHLORIDE 169 164 12 19
ATORVASTATIN CALCIUM 168 161 13 9
FUROSEMIDE 164 157 14 7
METFORMIN HCL ER 164 136 14 41
WARFARIN SODIUM 163 149 16 20
PRAVASTATIN SODIUM 156 127 17 8
ALLOPURINOL 153 140 18 29
LANTUS 153 114 18 54
GLIPIZIDE ER 151 134 20 68
TAMSULOSIN HCL 138 126 21 36
LOSARTAN POTASSIUM 134 115 22 18
FLUTICASONE PROPIONATE 128 119 23 32
METFORMIN HCL 115 87 24 10
NEXIUM 114 103 25 21
ATENOLOL 112 95 26 22
ALENDRONATE SODIUM 110 107 27 34
DONEPEZIL HCL 110 108 27 33
METOPROLOL SUCCINATE 108 82 29 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 84 30 27
NAMENDA 85 85 31 45
TRAMADOL HCL-ACETAMINOPHEN 85 73 31 144
SERTRALINE HCL 82 42 33 26
DOXYCYCLINE HYCLATE 73 56 34 141
CELEBREX 72 66 35 72
CLOPIDOGREL 70 50 36 30
JANUVIA 65 65 37 74
INSULIN SYRINGE 63 44 38 77
DIGOXIN 62 62 39 55
TRAZODONE HCL 61 55 40 51
ESCITALOPRAM OXALATE 56 56 41 67
DIOVAN 55 26 42 28
RANITIDINE HCL 55 37 42 25
AMLODIPINE BESYLATE-BENAZEPRIL 54 42 44 48
PREDNISONE 53 49 45 37
TRAMADOL HCL 51 47 46 16
CARVEDILOL 51 41 46 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.